This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Lucid dreaming | |
|---|---|
| Name | Lucid dreaming |
| Field | Oneirology |
Lucid dreaming is a state of sleep in which the sleeper is aware of dreaming while the dream is ongoing and may exert volitional control over dream content, actions, or environment. It is studied across Harvard University, University of Toronto, Max Planck Society, University of Adelaide, and by independent researchers associated with institutions such as the Lucidity Institute and the Monash University Sleep Lab. Interest spans psychology, neuroscience, psychiatry, and consciousness studies, with discussion appearing in venues tied to National Institutes of Health, American Psychological Association, Royal Society, World Sleep Society, and popular media outlets linked to figures like Stephen LaBerge, Sigmund Freud, Carl Jung, Aristotle, and Maurice Merleau-Ponty.
Lucid dreaming is characterized by meta-awareness of dreaming, episodic recall, and the potential for intentional modulation of dream events, typically occurring during rapid eye movement stages detected in polysomnography at centers such as Stanford University and University of California, Berkeley. Common phenomenology includes sensory vividness, altered time perception, emotional intensity, and rehearsed motor sequences; these traits have been documented in case series from Mayo Clinic, Cleveland Clinic, King's College London, University College London, and field reports tied to practitioners like Karl Popper-era philosophers and modern proponents such as Daniel Dennett. Phenomenological taxonomies reference historical reports connected to Plato, Ibn al-Nafis, Ibn Sina, Galen, and descriptive catalogs in collections maintained by British Museum and university archives at Columbia University.
Accounts of lucid dreaming appear in texts from Ancient Greece, Tang dynasty, Heian period, Aztec Empire, and indigenous oral traditions recorded by ethnographers at Smithsonian Institution and British Library. Cross-cultural evidence includes descriptions in the works of Aristotle, reports in Islamic Golden Age medical treatises linked to Ibn Sina, practice in Tibetan Buddhism Dream Yoga associated with lineages connected to Dalai Lama institutions, and ritual contexts documented by researchers at Harvard Divinity School and University of Oxford. Modern popularization traced through 19th- and 20th-century figures includes mentions by Carl Jung, experimental accounts by Sigmund Freud-influenced clinicians, and experimental protocols developed by Keith Hearne and Stephen LaBerge at Stanford University.
Neuroimaging and electrophysiology studies implicate prefrontal, parietal, and temporoparietal networks and neurotransmitter systems investigated at Massachusetts Institute of Technology, Max Planck Institute for Human Cognitive and Brain Sciences, University of Amsterdam, Yale University, and University of Pennsylvania. Findings associate lucid states with increased activity in dorsolateral and medial prefrontal cortices, anterior cingulate cortex, and parietal lobules, compared against REM patterns characterized in datasets from National Sleep Foundation and labs at University of California, Los Angeles. Neurochemical correlates reference cholinergic modulation studied in trials at Johns Hopkins University and dopaminergic markers examined in rodent models at Salk Institute. Sleep architecture, polysomnography metrics, and joystick signaling paradigms originate in work by Keith Hearne, Stephen LaBerge, and teams at University of Wisconsin–Madison.
Induction methods range from prospective memory strategies such as reality testing and mnemonic practices taught in programs at Lucidity Institute and cognitive training trials at University of Exeter, to sensory stimulation protocols using auditory, tactile, and visual cues trialed at Massachusetts General Hospital and Karolinska Institutet. Pharmacological augmentation experiments have involved cholinergic agents researched at University of Oxford and supplements assessed in studies from University of Sydney and University of Melbourne. Technological approaches include wearable devices developed with partners at MIT Media Lab, consumer products marketed by startups linked to accelerators like Y Combinator, and laboratory stimulation paradigms combining transcranial alternating current stimulation trials at University of Zurich and University of Milan.
Practitioners and clinicians explore lucid dreaming for nightmare treatment in protocols implemented at McGill University, University of Pittsburgh Medical Center, and military veteran programs linked to Department of Veterans Affairs. Therapeutic research intersects with trauma-focused work at Yale School of Medicine and behavioral therapies tested at University of Michigan. Creative problem-solving, skill rehearsal, and pain management applications are topics of pilot studies at Princeton University, Columbia University, and University of Chicago, while ethics and safety considerations have been debated at conferences hosted by American Academy of Sleep Medicine and symposia organized by Society for Neuroscience.
Concerns include sleep fragmentation, dissociation, and exacerbation of psychiatric symptoms reported in clinical case reports from UCLA Health, National Institute of Mental Health, Kings College Hospital, and forensic assessments in medico-legal contexts involving institutions like Royal Courts of Justice. Debates over cognitive enhancement, informed consent in experimental induction, and commercialization are litigated in regulatory discussions with Food and Drug Administration and consumer protection dialogues involving Federal Trade Commission. Ethical discourse engages bioethicists at Hastings Center, philosophers from University of Cambridge, and policy analysts at Brookings Institution.
Empirical approaches combine subjective dream reports, standardized questionnaires developed at University of Iowa and University of Freiburg, and objective markers including prearranged eye-movement signals recorded via polysomnography in laboratories such as Stanford University Sleep Lab and University Hospital Zürich. Experimental paradigms utilize randomized controlled trials at King's College London, single-case designs at University of Sheffield, neuroimaging at Imperial College London and University College London, and longitudinal cohorts tracked by consortia involving National Institutes of Health, European Research Council, and cross-disciplinary teams at International Association for the Study of Dreams.